IL231070A0 - Estrogen receptor and methods of use thereof - Google Patents
Estrogen receptor and methods of use thereofInfo
- Publication number
- IL231070A0 IL231070A0 IL231070A IL23107014A IL231070A0 IL 231070 A0 IL231070 A0 IL 231070A0 IL 231070 A IL231070 A IL 231070A IL 23107014 A IL23107014 A IL 23107014A IL 231070 A0 IL231070 A0 IL 231070A0
- Authority
- IL
- Israel
- Prior art keywords
- methods
- estrogen receptor
- estrogen
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/215,679 US9427418B2 (en) | 2009-02-23 | 2011-08-23 | Estrogen receptor ligands and methods of use thereof |
PCT/US2012/052141 WO2013043304A1 (en) | 2009-02-23 | 2012-08-23 | Estrogen receptor ligands and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL231070A0 true IL231070A0 (en) | 2014-03-31 |
Family
ID=48444651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL231070A IL231070A0 (en) | 2011-08-23 | 2014-02-20 | Estrogen receptor and methods of use thereof |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2747562A4 (en) |
JP (1) | JP2014524479A (en) |
KR (1) | KR20140064906A (en) |
CN (1) | CN103957706A (en) |
AU (1) | AU2012312902B2 (en) |
CA (1) | CA2845890A1 (en) |
IL (1) | IL231070A0 (en) |
IN (1) | IN2014DN01959A (en) |
MX (1) | MX2014002105A (en) |
RU (1) | RU2014111060A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL273195B2 (en) * | 2017-09-27 | 2024-04-01 | Targimmune Therapeutics Ag | Castration resistant prostate cancer |
JP2022523746A (en) * | 2019-02-01 | 2022-04-26 | フォンダツィオーネ・ペア・リスチチュート・オンコロジコ・ディ・リチェルカ・(イオエッレ) | How to Treat Castration-Resistant Prostate Cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8158828B2 (en) * | 2005-11-28 | 2012-04-17 | Gtx, Inc. | Nuclear receptor binding agents |
US8546451B2 (en) * | 2005-11-28 | 2013-10-01 | Gtx, Inc. | Estrogen receptor ligands and methods of use thereof |
CA2824517A1 (en) * | 2005-11-28 | 2007-05-31 | Gtx, Inc. | Nuclear receptor binding agents |
MX340753B (en) * | 2009-02-23 | 2016-07-25 | Gtx Inc | Estrogen receptor ligands and methods of use thereof. |
-
2012
- 2012-08-23 CA CA2845890A patent/CA2845890A1/en not_active Abandoned
- 2012-08-23 MX MX2014002105A patent/MX2014002105A/en unknown
- 2012-08-23 RU RU2014111060/15A patent/RU2014111060A/en not_active Application Discontinuation
- 2012-08-23 IN IN1959DEN2014 patent/IN2014DN01959A/en unknown
- 2012-08-23 KR KR1020147007549A patent/KR20140064906A/en not_active Application Discontinuation
- 2012-08-23 CN CN201280051979.4A patent/CN103957706A/en active Pending
- 2012-08-23 AU AU2012312902A patent/AU2012312902B2/en not_active Ceased
- 2012-08-23 JP JP2014527312A patent/JP2014524479A/en active Pending
- 2012-08-23 EP EP12834287.0A patent/EP2747562A4/en not_active Withdrawn
-
2014
- 2014-02-20 IL IL231070A patent/IL231070A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2012312902B2 (en) | 2016-03-17 |
MX2014002105A (en) | 2014-09-25 |
CA2845890A1 (en) | 2013-03-28 |
RU2014111060A (en) | 2015-09-27 |
AU2012312902A1 (en) | 2013-05-23 |
EP2747562A1 (en) | 2014-07-02 |
CN103957706A (en) | 2014-07-30 |
KR20140064906A (en) | 2014-05-28 |
IN2014DN01959A (en) | 2015-05-15 |
JP2014524479A (en) | 2014-09-22 |
EP2747562A4 (en) | 2015-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1255608A1 (en) | Anti-htra1 antibodies and methods of use | |
IL227440B (en) | Ballstent device and methods of use | |
HK1198165A1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
EP2721063A4 (en) | Pcsk9-binding polypeptides and methods of use | |
SI2683731T1 (en) | C4-monomethyl triterpenoid derivatives and methods of use thereof | |
EP2670866A4 (en) | Biomarkers and methods of use thereof | |
ZA201403760B (en) | Anti-cd98 antibodies and methods of use thereof | |
ZA201401653B (en) | Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use | |
HK1201843A1 (en) | Anti-polyubiquitin antibodies and methods of use | |
EP2776437A4 (en) | Modulators of opioid receptors and methods of use thereof | |
EP2558496A4 (en) | Anti-polyubiquitin antibodies and methods of use | |
ZA201300174B (en) | Anti-neuropilin antibodies and methods of use | |
EP2538780A4 (en) | Estrogen receptor ligands and methods of use thereof | |
EP2709999A4 (en) | Quinazoline-7-ether compounds and methods of use | |
EP2670245A4 (en) | Alpha-ketoheterocycles and methods of making and using | |
IL231070A0 (en) | Estrogen receptor and methods of use thereof | |
EP2776462A4 (en) | Indolealkylamino-withasteroid conjugates and method of use |